CN118126019A - Preparation method of alpha-lipoic acid - Google Patents
Preparation method of alpha-lipoic acid Download PDFInfo
- Publication number
- CN118126019A CN118126019A CN202410552879.4A CN202410552879A CN118126019A CN 118126019 A CN118126019 A CN 118126019A CN 202410552879 A CN202410552879 A CN 202410552879A CN 118126019 A CN118126019 A CN 118126019A
- Authority
- CN
- China
- Prior art keywords
- chloroform
- adipate
- monoethyl
- monoethyl adipate
- lipoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 title claims abstract description 71
- 235000019136 lipoic acid Nutrition 0.000 title claims abstract description 49
- 229960002663 thioctic acid Drugs 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title abstract description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 130
- UZNLHJCCGYKCIL-UHFFFAOYSA-N 6-ethoxy-6-oxohexanoic acid Chemical compound CCOC(=O)CCCCC(O)=O UZNLHJCCGYKCIL-UHFFFAOYSA-N 0.000 claims abstract description 89
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- 238000000605 extraction Methods 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000002253 acid Substances 0.000 claims abstract description 14
- 238000004090 dissolution Methods 0.000 claims abstract description 6
- 239000012074 organic phase Substances 0.000 claims description 26
- 230000020477 pH reduction Effects 0.000 claims description 25
- 239000008367 deionised water Substances 0.000 claims description 24
- 229910021641 deionized water Inorganic materials 0.000 claims description 24
- 239000012071 phase Substances 0.000 claims description 21
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 18
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 230000007062 hydrolysis Effects 0.000 claims description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000007259 addition reaction Methods 0.000 claims description 8
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 7
- VEOZBFFLKPBVIY-UHFFFAOYSA-N ethyl 6-chloro-6-oxohexanoate Chemical compound CCOC(=O)CCCCC(Cl)=O VEOZBFFLKPBVIY-UHFFFAOYSA-N 0.000 claims description 7
- -1 adipic acid monoethyl ester acyl chloride Chemical class 0.000 claims description 6
- FUFHKMOUERGVRB-UHFFFAOYSA-N 6-ethoxy-6-oxohexanoic acid;hydrochloride Chemical compound Cl.CCOC(=O)CCCCC(O)=O FUFHKMOUERGVRB-UHFFFAOYSA-N 0.000 claims description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- 239000005977 Ethylene Substances 0.000 claims description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 238000005660 chlorination reaction Methods 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 238000006722 reduction reaction Methods 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims 5
- 238000010668 complexation reaction Methods 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 238000007599 discharging Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000002699 waste material Substances 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract description 38
- VIZORQUEIQEFRT-UHFFFAOYSA-N Diethyl adipate Chemical compound CCOC(=O)CCCCC(=O)OCC VIZORQUEIQEFRT-UHFFFAOYSA-N 0.000 abstract description 21
- 238000004821 distillation Methods 0.000 abstract description 7
- 159000000000 sodium salts Chemical class 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000015556 catabolic process Effects 0.000 abstract description 3
- 238000006731 degradation reaction Methods 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 50
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 26
- 239000008346 aqueous phase Substances 0.000 description 26
- 238000010586 diagram Methods 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 238000004817 gas chromatography Methods 0.000 description 14
- 238000004811 liquid chromatography Methods 0.000 description 14
- 239000012535 impurity Substances 0.000 description 11
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 10
- NDSGOBVTOHVLGW-UHFFFAOYSA-N 2-ethylhexanedioyl dichloride Chemical compound CCC(C(Cl)=O)CCCC(Cl)=O NDSGOBVTOHVLGW-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 239000001361 adipic acid Substances 0.000 description 5
- 235000011037 adipic acid Nutrition 0.000 description 5
- 239000013557 residual solvent Substances 0.000 description 5
- 238000013517 stratification Methods 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 238000010146 3D printing Methods 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RFYDWSNYTVVKBR-UHFFFAOYSA-N ethyl 6,8-dichlorooctanoate Chemical compound CCOC(=O)CCCCC(Cl)CCCl RFYDWSNYTVVKBR-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000005486 sulfidation Methods 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供一种α‑硫辛酸的制备方法,该方法根据溶解pH 6.85~6.95时,己二酸单乙酯反应生成钠盐,溶于水;而己二酸二乙酯和甲苯溶于氯仿,能够针对性的去除己二酸二乙酯和甲苯;酸化萃取时,钠盐与盐酸反应生成己二酸单乙酯,同时根据不同pH,己二酸单乙酯在水中溶解度的差异,获得较高的萃取收率,且该方法避免了高温精馏导致的产品热降解,能够获得高纯度的己二酸单乙酯,该方法操作简单,有效降低了生产成本,不但解决了己二酸二乙酯去除的问题,同时解决了己二酸单乙酯中残留甲苯参与后续反应的问题,最终能够提高α‑硫辛酸的收率。
The invention provides a preparation method of alpha-lipoic acid. According to the method, when the dissolution pH is 6.85-6.95, monoethyl adipate reacts to generate sodium salt, which is dissolved in water; diethyl adipate and toluene are dissolved in chloroform, and diethyl adipate and toluene can be removed in a targeted manner; during acid extraction, the sodium salt reacts with hydrochloric acid to generate monoethyl adipate, and according to the difference in solubility of monoethyl adipate in water at different pH values, a higher extraction yield is obtained, and the method avoids thermal degradation of the product caused by high-temperature distillation, and can obtain high-purity monoethyl adipate. The method is simple to operate, effectively reduces the production cost, not only solves the problem of removing diethyl adipate, but also solves the problem of residual toluene in monoethyl adipate participating in subsequent reactions, and finally can improve the yield of alpha-lipoic acid.
Description
技术领域Technical Field
本发明涉及新材料技术领域,特别是涉及一种α-硫辛酸的制备方法。The invention relates to the technical field of new materials, and in particular to a method for preparing alpha-lipoic acid.
背景技术Background technique
α-硫辛酸又名硫辛酸(ALA),化学名:1,2-二硫戊环-3-戊酸,是一种辅酶,存在于线粒体中。α-硫辛酸因其独特的抗氧化性,在新材料研究领域,受到研究学者的广泛关注。例如,相关研究人员以α-硫辛酸为材料,利用α-硫辛酸的热响应开环聚合特性,形成聚硫辛酸,制备了基于聚硫辛酸的粘合剂,利用该粘合剂的时间依赖自增强效应,将其应用在热熔沉积的3D打印中,通过聚硫辛酸的3D打印,完全实现了不同尺度上的模型形成。3D打印后,聚硫辛酸打印的模型随着时间的推移表现出机械增强的特征,研究表明这是由聚硫辛酸和硫辛酸的微观自组装引起的。这项工作实现了微观层面的自组装和宏观层面的自组装有机结合。该研究也为粘合材料的可控制造和机械增强提供了一种可行的方法,为下一代功能粘合材料的应用开辟了道路。此外,α-硫辛酸还可改善糖尿病患者的胰岛素功能与心率变异数;能治疗丙型肝炎、保护肾脏、胰脏、预防白内障等疾病,α-硫辛酸还可用于化妆品、饲料、摄影技术等领域。因此,研究α-硫辛酸的制备对新材料的研发具有重要意义。α-Lipoic acid, also known as lipoic acid (ALA), has a chemical name of 1,2-dithiolane-3-pentanoic acid. It is a coenzyme that exists in mitochondria. Due to its unique antioxidant properties, α-lipoic acid has attracted extensive attention from researchers in the field of new materials research. For example, relevant researchers used α-lipoic acid as a material, utilized the thermal response ring-opening polymerization characteristics of α-lipoic acid, formed polylipoic acid, prepared a polylipoic acid-based adhesive, and used the time-dependent self-enhancement effect of the adhesive to apply it in hot melt deposition 3D printing. Through the 3D printing of polylipoic acid, the model formation on different scales was fully realized. After 3D printing, the model printed by polylipoic acid showed mechanical enhancement characteristics over time. Studies have shown that this is caused by the microscopic self-assembly of polylipoic acid and lipoic acid. This work realizes the organic combination of self-assembly at the microscopic level and self-assembly at the macroscopic level. This study also provides a feasible method for the controllable manufacturing and mechanical enhancement of adhesive materials, paving the way for the application of the next generation of functional adhesive materials. In addition, α-lipoic acid can improve the insulin function and heart rate variability of diabetic patients; it can treat hepatitis C, protect the kidneys and pancreas, prevent cataracts and other diseases. α-lipoic acid can also be used in cosmetics, feed, photography technology and other fields. Therefore, the study of the preparation of α-lipoic acid is of great significance to the research and development of new materials.
目前,请参阅图1,α-硫辛酸主要是以己二酸为起始物料,先制备6,8-二氯辛酸乙酯粗品,6,8-二氯辛酸乙酯粗品经过蒸馏纯化后,再经过硫化、水解、酸化等步骤制备得到。其中,己二酸单乙酯是以己二酸为起始物料,甲苯为溶剂,经酯化反应生成,其主要有机杂质是己二酸二乙酯,溶剂残留为甲苯,己二酸单乙酯中残留溶剂甲苯在无水AlCl3催化条件下与6-氧代-6-氯己酸乙酯反应,形成杂质A(杂质A的形成路线请参阅图2),影响6-氧代-6-氯己酸乙酯的纯度,最终影响α-硫辛酸的收率。At present, please refer to Figure 1. α-lipoic acid is mainly prepared by using adipic acid as the starting material, first preparing crude 6,8-dichlorooctanoic acid ethyl ester, and then preparing it through steps such as sulfidation, hydrolysis, and acidification after the crude 6,8-dichlorooctanoic acid ethyl ester is purified by distillation. Among them, monoethyl adipate is produced by using adipic acid as the starting material and toluene as the solvent through esterification reaction. Its main organic impurity is diethyl adipate, and the residual solvent is toluene. The residual solvent toluene in monoethyl adipate reacts with 6-oxo-6-chlorohexanoic acid ethyl ester under the catalytic condition of anhydrous AlCl 3 to form impurity A (please refer to Figure 2 for the formation route of impurity A), which affects the purity of 6-oxo-6-chlorohexanoic acid ethyl ester and ultimately affects the yield of α-lipoic acid.
相关技术还采用了己二酸单乙酯精馏的方法,但在对己二酸单乙酯的蒸馏过程中,由于己二酸二乙酯沸点低于己二酸单乙酯,因而己二酸二乙酯率先蒸出,少量的己二酸二乙酯蒸出后,大量的己二酸单乙酯在反应釜内只能通过提高温度才可以蒸出,己二酸单乙酯在高温环境下长时间蒸馏易导致受热分解,经实验测试分解程度约为4%,影响己二酸单乙酯的纯度和收率,最终影响α-硫辛酸的收率。除此之外,高温蒸馏不但对生产存在安全隐患,而且能耗较高。The related technology also uses a method of distilling monoethyl adipate, but in the distillation process of monoethyl adipate, since the boiling point of diethyl adipate is lower than that of monoethyl adipate, diethyl adipate is evaporated first. After a small amount of diethyl adipate is evaporated, a large amount of monoethyl adipate can only be evaporated by increasing the temperature in the reactor. Long-term distillation of monoethyl adipate in a high temperature environment is prone to thermal decomposition. The degree of decomposition is about 4% according to experimental tests, which affects the purity and yield of monoethyl adipate, and ultimately affects the yield of α-lipoic acid. In addition, high-temperature distillation not only poses a safety hazard to production, but also consumes a lot of energy.
发明内容Summary of the invention
为此,本发明提出一种α-硫辛酸的制备方法,以解决有机杂质己二酸二乙酯和残留溶剂甲苯影响己二酸单乙酯的纯度和收率,进而影响α-硫辛酸的收率的问题。Therefore, the present invention provides a method for preparing alpha-lipoic acid to solve the problem that the organic impurity diethyl adipate and the residual solvent toluene affect the purity and yield of monoethyl adipate, and further affect the yield of alpha-lipoic acid.
本发明提供一种α-硫辛酸的制备方法,包括以下步骤;The present invention provides a method for preparing alpha-lipoic acid, comprising the following steps:
步骤1,控制温度在20~25℃,依次向溶解釜中加入己二酸单乙酯粗品和去离子水,使用10%碳酸氢钠将pH调至6.85~6.95;Step 1, controlling the temperature at 20-25° C., adding crude monoethyl adipate and deionized water to a dissolving kettle in sequence, and adjusting the pH to 6.85-6.95 using 10% sodium bicarbonate;
步骤2,控制温度在20~25℃,向溶解釜中加入氯仿进行萃取,搅拌25~30min,静置分层,将水相转移到酸化釜,待调酸;Step 2, controlling the temperature at 20-25°C, adding chloroform to the dissolution kettle for extraction, stirring for 25-30 minutes, standing for stratification, and transferring the aqueous phase to the acidification kettle for acidification;
步骤3,向氯仿相加入去离子水,然后使用10%碳酸氢钠将pH调至6.85~6.95,搅拌反萃取10~15min,将上层水相转到酸化釜,待调酸,对有机相进行氯仿回收;Step 3, add deionized water to the chloroform phase, then use 10% sodium bicarbonate to adjust the pH to 6.85-6.95, stir and back extract for 10-15 minutes, transfer the upper aqueous phase to the acidification kettle, wait for acid adjustment, and recover chloroform from the organic phase;
步骤4,控制温度在20~25℃,酸化釜中的水相用15%盐酸将pH调至2.5~3.5;Step 4, controlling the temperature at 20-25°C, and adjusting the pH of the aqueous phase in the acidification kettle to 2.5-3.5 with 15% hydrochloric acid;
步骤5,控制温度在20~25℃,静置分层,下层为己二酸单乙酯,上层水相待萃取;Step 5, controlling the temperature at 20-25°C, standing and separating the layers, the lower layer is monoethyl adipate, and the upper layer is water to be extracted;
步骤6,酸化釜上层水相氯仿萃取三次,每次萃取后静置分层;Step 6, extracting the upper aqueous phase of the acidified kettle with chloroform three times, and standing and stratifying after each extraction;
步骤7,水相第三次萃取后排废,将氯仿相与步骤5得到的己二酸单乙酯合并后,使用饱和氯化钠溶液搅拌洗涤25~30min,静置分层,有机相待浓缩;Step 7, after the aqueous phase is extracted for the third time, the aqueous phase is discharged, the chloroform phase is combined with the monoethyl adipate obtained in step 5, and then the chloroform phase is washed with a saturated sodium chloride solution with stirring for 25 to 30 minutes, and the organic phase is concentrated after standing for stratification;
步骤8,控制温度在20~40℃,真空浓缩步骤7的有机相回收氯仿,得到己二酸单乙酯纯品;Step 8, controlling the temperature at 20-40° C., vacuum concentrating the organic phase of step 7 to recover chloroform, and obtaining pure monoethyl adipate;
步骤9,基于己二酸单乙酯纯品制备己二酸单乙酯酰氯;Step 9, preparing monoethyl adipate chloride based on pure monoethyl adipate;
步骤10,基于己二酸单乙酯酰氯制备α-硫辛酸。Step 10, preparing α-lipoic acid based on ethyl adipic acid chloride.
本发明提供的α-硫辛酸的制备方法,根据溶解pH 6.85~6.95时,己二酸单乙酯(酸度系数4.69±0.1)反应生成钠盐,溶于水;而己二酸二乙酯和甲苯溶于氯仿,能够针对性的去除己二酸二乙酯和甲苯;酸化萃取时,钠盐与盐酸反应生成己二酸单乙酯,同时根据不同pH,己二酸单乙酯在水中溶解度的差异,获得较高的萃取收率,且该方法避免了高温精馏导致的产品热降解,能够获得高纯度的己二酸单乙酯,该方法操作简单,有效降低了生产成本,不但解决了己二酸二乙酯去除的问题,而且解决了己二酸单乙酯的残留溶剂甲苯参与反应生成杂质的问题,最终能够提高α-硫辛酸的收率。The preparation method of alpha-lipoic acid provided by the invention comprises the following steps: when the dissolution pH is 6.85-6.95, monoethyl adipate (acidity coefficient 4.69±0.1) reacts to generate sodium salt, which is dissolved in water; and diethyl adipate and toluene are dissolved in chloroform, so that diethyl adipate and toluene can be removed in a targeted manner; during acid extraction, the sodium salt reacts with hydrochloric acid to generate monoethyl adipate, and at the same time, according to the difference in solubility of monoethyl adipate in water at different pH values, a higher extraction yield is obtained, and the method avoids thermal degradation of the product caused by high-temperature distillation, so that high-purity monoethyl adipate can be obtained. The method is simple to operate, effectively reduces the production cost, solves the problem of removing diethyl adipate, and solves the problem of residual solvent toluene of monoethyl adipate participating in the reaction to generate impurities, and finally improves the yield of alpha-lipoic acid.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是α-硫辛酸的合成路线图;Fig. 1 is a synthetic route diagram of α-lipoic acid;
图2是杂质A的形成路线图;FIG2 is a formation route diagram of impurity A;
图3是实施例1的液相色谱结果图;Fig. 3 is a liquid chromatography result diagram of Example 1;
图4是实施例1的气相色谱结果图;Fig. 4 is a gas chromatography result diagram of Example 1;
图5是实施例2的液相色谱结果图;Fig. 5 is a liquid chromatography result diagram of Example 2;
图6是实施例2的气相色谱结果图;Fig. 6 is a gas chromatography result diagram of Example 2;
图7是实施例3的液相色谱结果图;Fig. 7 is a diagram of the liquid chromatography results of Example 3;
图8是实施例3的气相色谱结果图;FIG8 is a gas chromatography result diagram of Example 3;
图9是对比例1的液相色谱结果图;FIG9 is a liquid chromatography result diagram of Comparative Example 1;
图10是对比例1的气相色谱结果图;Figure 10 is a gas chromatography result diagram of Comparative Example 1;
图11是对比例2的液相色谱结果图;Figure 11 is a liquid chromatography result diagram of Comparative Example 2;
图12是对比例2的气相色谱结果图;Figure 12 is a gas chromatography result diagram of Comparative Example 2;
图13是对比例3的液相色谱结果图;Figure 13 is a liquid chromatography result diagram of Comparative Example 3;
图14是对比例3的气相色谱结果图;Figure 14 is a gas chromatography result diagram of Comparative Example 3;
图15是对比例4的液相色谱结果图;Figure 15 is a liquid chromatography result diagram of Comparative Example 4;
图16是对比例4的气相色谱结果图;Figure 16 is a gas chromatography result diagram of Comparative Example 4;
图17是对比例5的液相色谱结果图;Figure 17 is a liquid chromatography result diagram of Comparative Example 5;
图18是对比例5的气相色谱结果图;Figure 18 is a gas chromatography result diagram of Comparative Example 5;
图19是对比例6的液相色谱结果图;Figure 19 is a liquid chromatography result diagram of Comparative Example 6;
图20是对比例6的气相色谱结果图;Figure 20 is a gas chromatography result diagram of Comparative Example 6;
图21是对比例7的液相色谱结果图;Figure 21 is a liquid chromatography result diagram of Comparative Example 7;
图22是对比例7的气相色谱结果图;Figure 22 is a gas chromatography result diagram of Comparative Example 7;
图23是对比例8的液相色谱结果图;Figure 23 is a liquid chromatography result diagram of Comparative Example 8;
图24是对比例8的气相色谱结果图。Figure 24 is a graph showing the gas chromatography results of Comparative Example 8.
具体实施方式Detailed ways
为了便于理解本发明,下面将参照各实施例对本发明进行更全面的描述,但是,本发明可以以许多不同的形式来实现,并不限于本文所描述的实施例。相反地,提供这些实施例的目的是使对本发明的公开内容更加透彻全面。In order to facilitate the understanding of the present invention, the present invention will be described more fully below with reference to various embodiments, but the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the disclosure of the present invention more thorough and comprehensive.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。本文所使用的术语“及/或”包括一个或多个相关的所列项目的任意的和所有的组合。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and/or" used herein includes any and all combinations of one or more of the related listed items.
下面分多个实施例对本发明实施例进行进一步的说明。本发明实施例不限定于以下的具体实施例。在不变主权利的范围内,可以适当的进行变更实施。The following is a further description of the embodiments of the present invention in multiple embodiments. The embodiments of the present invention are not limited to the following specific embodiments. Within the scope of the unchanged main rights, appropriate changes can be made to the implementation.
实施例1Example 1
步骤1,控制温度在20~25℃,依次向溶解釜中加入己二酸单乙酯粗品和去离子水,己二酸单乙酯粗品与去离子水的质量比为1:3,使用10%碳酸氢钠将pH调至6.9;Step 1, controlling the temperature at 20-25° C., adding crude monoethyl adipate and deionized water to a dissolving kettle in sequence, wherein the mass ratio of crude monoethyl adipate to deionized water is 1:3, and adjusting the pH to 6.9 using 10% sodium bicarbonate;
步骤2,控制温度在20~25℃,向溶解釜中加入氯仿进行萃取,氯仿与己二酸单乙酯粗品的质量比为1:1,搅拌25~30min,静置分层,将水相转移到酸化釜,待调酸;Step 2, controlling the temperature at 20-25°C, adding chloroform to the dissolving kettle for extraction, the mass ratio of chloroform to the crude monoethyl adipate being 1:1, stirring for 25-30 minutes, standing for stratification, transferring the aqueous phase to the acidifying kettle for acidification;
步骤3,向氯仿相加入去离子水,氯仿与去离子水的质量比为1:1,然后使用10%碳酸氢钠将pH调至6.9,搅拌反萃取10~15min,将上层水相转到酸化釜,待调酸,对有机相进行氯仿回收;Step 3, adding deionized water to the chloroform phase, the mass ratio of chloroform to deionized water is 1:1, and then adjusting the pH to 6.9 with 10% sodium bicarbonate, stirring and back-extracting for 10-15 minutes, transferring the upper aqueous phase to an acidification kettle, waiting for acid adjustment, and recovering chloroform from the organic phase;
步骤4,控制温度在20~25℃,酸化釜中的水相用15%盐酸将pH调至3.0;Step 4, controlling the temperature at 20-25°C, and adjusting the pH of the aqueous phase in the acidification kettle to 3.0 with 15% hydrochloric acid;
步骤5,控制温度在20~25℃,静置分层,下层为己二酸单乙酯,上层水相待萃取;Step 5, controlling the temperature at 20-25°C, standing and separating the layers, the lower layer is monoethyl adipate, and the upper layer is water to be extracted;
步骤6,酸化釜上层水相氯仿萃取三次,每次萃取后静置分层,每次萃取使用氯仿的质量与步骤1中己二酸单乙酯粗品的质量比为1:1;Step 6, extracting the upper aqueous phase of the acidified kettle with chloroform three times, standing and stratifying after each extraction, and the mass ratio of the chloroform used in each extraction to the mass ratio of the crude monoethyl adipate in step 1 is 1:1;
步骤7,水相第三次萃取后排废,将氯仿相与步骤5得到的己二酸单乙酯合并后,使用饱和氯化钠溶液搅拌洗涤25~30min,饱和氯化钠溶液的质量与步骤1中己二酸单乙酯粗品的质量比为0.5:1,静置分层,有机相待浓缩;Step 7, after the aqueous phase is extracted for the third time, the aqueous phase is discharged, the chloroform phase is combined with the monoethyl adipate obtained in step 5, and then the chloroform phase is stirred and washed for 25 to 30 minutes with a saturated sodium chloride solution, wherein the mass ratio of the saturated sodium chloride solution to the crude monoethyl adipate in step 1 is 0.5:1, the organic phase is allowed to stand and the layers are separated, and the organic phase is to be concentrated;
步骤8,控制温度在20~40℃,真空浓缩步骤7的有机相回收氯仿,得到己二酸单乙酯纯品;Step 8, controlling the temperature at 20-40° C., vacuum concentrating the organic phase of step 7 to recover chloroform, and obtaining pure monoethyl adipate;
步骤9,基于己二酸单乙酯纯品制备己二酸单乙酯酰氯;Step 9, preparing monoethyl adipate chloride based on pure monoethyl adipate;
步骤9具体包括:Step 9 specifically includes:
步骤9.1,向反应釜中加入氯仿、己二酸单乙酯纯品,降温至0℃;Step 9.1, add chloroform and pure monoethyl adipate into the reaction kettle and cool to 0°C;
步骤9.2,控制温度在0~10℃,流加氯仿和氯化亚砜;Step 9.2, controlling the temperature at 0-10°C, adding chloroform and thionyl chloride;
步骤9.3,氯化亚砜流加完后,控制温度5~10℃,反应2h;Step 9.3, after the addition of thionyl chloride, the temperature was controlled at 5-10°C and the reaction was carried out for 2 hours;
步骤9.4,升温至40±2℃,保温反应2h;Step 9.4, raise the temperature to 40±2°C and keep the reaction for 2h;
步骤9.5,升温至70±2℃,保温反应1h;Step 9.5, raise the temperature to 70±2°C and keep the reaction for 1 hour;
步骤9.6,反应结束,冷却至15~20℃,得到己二酸单乙酯酰氯;Step 9.6, after the reaction is completed, the mixture is cooled to 15-20° C. to obtain ethyl adipic acid chloride;
步骤10,基于己二酸单乙酯酰氯制备α-硫辛酸;Step 10, preparing α-lipoic acid based on ethyl adipic acid chloride;
步骤10具体包括:Step 10 specifically includes:
向己二酸单乙酯酰氯中加入无水三氯化铝,控制温度在15~20℃,络合反应2h,得到6-氧代-6-氯己酸乙酯络合反应液,然后通入乙烯进行加成反应,加成反应结束,转入去离子水进行水解,分层得到有机相,向有机相加入乙醇和硼氢化钾进行还原反应,然后依次进行氯代反应、环合反应、水解和酸化制备得到α-硫辛酸。Anhydrous aluminum chloride is added to ethyl adipic acid monochloride, the temperature is controlled at 15-20°C, and the complex reaction is carried out for 2 hours to obtain 6-oxo-6-chlorohexanoic acid ethyl ester complex reaction liquid, and then ethylene is introduced for addition reaction. After the addition reaction is completed, deionized water is added for hydrolysis, and the organic phase is obtained by layering. Ethanol and potassium borohydride are added to the organic phase for reduction reaction, and then chlorination reaction, cyclization reaction, hydrolysis and acidification are carried out in sequence to prepare α-lipoic acid.
实施例2Example 2
步骤1,控制温度在20~25℃,依次向溶解釜中加入己二酸单乙酯粗品和去离子水,己二酸单乙酯粗品与去离子水的质量比为1:3,使用10%碳酸氢钠将pH调至6.85;Step 1, controlling the temperature at 20-25° C., adding crude monoethyl adipate and deionized water to a dissolving kettle in sequence, wherein the mass ratio of crude monoethyl adipate to deionized water is 1:3, and adjusting the pH to 6.85 using 10% sodium bicarbonate;
步骤2,控制温度在20~25℃,向溶解釜中加入氯仿进行萃取,氯仿与己二酸单乙酯粗品的质量比为1:1,搅拌25~30min,静置分层,将水相转移到酸化釜,待调酸;Step 2, controlling the temperature at 20-25°C, adding chloroform to the dissolving kettle for extraction, the mass ratio of chloroform to the crude monoethyl adipate being 1:1, stirring for 25-30 minutes, standing for stratification, transferring the aqueous phase to the acidifying kettle for acidification;
步骤3,向氯仿相加入去离子水,氯仿与去离子水的质量比为1:1,然后使用10%碳酸氢钠将pH调至6.85,搅拌反萃取10~15min,将上层水相转到酸化釜,待调酸,对有机相进行氯仿回收;Step 3, adding deionized water to the chloroform phase, the mass ratio of chloroform to deionized water is 1:1, and then adjusting the pH to 6.85 with 10% sodium bicarbonate, stirring and back-extracting for 10-15 minutes, transferring the upper aqueous phase to an acidification kettle, waiting for acid adjustment, and recovering chloroform from the organic phase;
步骤4,控制温度在20~25℃,酸化釜中的水相用15%盐酸将pH调至2.5;Step 4, controlling the temperature at 20-25°C, and adjusting the pH of the aqueous phase in the acidification kettle to 2.5 with 15% hydrochloric acid;
步骤5,控制温度在20~25℃,静置分层,下层为己二酸单乙酯,上层水相待萃取;Step 5, controlling the temperature at 20-25°C, standing and separating the layers, the lower layer is monoethyl adipate, and the upper layer is water to be extracted;
步骤6,酸化釜上层水相氯仿萃取三次,每次萃取后静置分层,每次萃取使用氯仿的质量与步骤1中己二酸单乙酯粗品的质量比为1:1;Step 6, extracting the upper aqueous phase of the acidified kettle with chloroform three times, standing and stratifying after each extraction, and the mass ratio of the chloroform used in each extraction to the mass ratio of the crude monoethyl adipate in step 1 is 1:1;
步骤7,水相第三次萃取后排废,将氯仿相与步骤5得到的己二酸单乙酯合并后,使用饱和氯化钠溶液搅拌洗涤25~30min,饱和氯化钠溶液的质量与步骤1中己二酸单乙酯粗品的质量比为0.5:1,静置分层,有机相待浓缩;Step 7, after the aqueous phase is extracted for the third time, the aqueous phase is discharged, the chloroform phase is combined with the monoethyl adipate obtained in step 5, and then the chloroform phase is stirred and washed for 25 to 30 minutes with a saturated sodium chloride solution, wherein the mass ratio of the saturated sodium chloride solution to the crude monoethyl adipate in step 1 is 0.5:1, the organic phase is allowed to stand and the layers are separated, and the organic phase is to be concentrated;
步骤8,控制温度在20~40℃,真空浓缩步骤7的有机相回收氯仿,得到己二酸单乙酯纯品;Step 8, controlling the temperature at 20-40° C., vacuum concentrating the organic phase of step 7 to recover chloroform, and obtaining pure monoethyl adipate;
步骤9,基于己二酸单乙酯纯品制备己二酸单乙酯酰氯;Step 9, preparing monoethyl adipate chloride based on pure monoethyl adipate;
步骤9具体包括:Step 9 specifically includes:
步骤9.1,向反应釜中加入氯仿、己二酸单乙酯纯品,降温至0℃;Step 9.1, add chloroform and pure monoethyl adipate into the reaction kettle and cool to 0°C;
步骤9.2,控制温度在0~10℃,流加氯仿和氯化亚砜;Step 9.2, controlling the temperature at 0-10°C, adding chloroform and thionyl chloride;
步骤9.3,氯化亚砜流加完后,控制温度5~10℃,反应2h;Step 9.3, after the addition of thionyl chloride, the temperature was controlled at 5-10°C and the reaction was carried out for 2 hours;
步骤9.4,升温至40±2℃,保温反应2h;Step 9.4, raise the temperature to 40±2°C and keep the reaction for 2h;
步骤9.5,升温至70±2℃,保温反应1h;Step 9.5, raise the temperature to 70±2°C and keep the reaction for 1 hour;
步骤9.6,反应结束,冷却至15~20℃,得到己二酸单乙酯酰氯;Step 9.6, after the reaction is completed, the mixture is cooled to 15-20° C. to obtain ethyl adipic acid chloride;
步骤10,基于己二酸单乙酯酰氯制备α-硫辛酸;Step 10, preparing α-lipoic acid based on ethyl adipic acid chloride;
步骤10具体包括:Step 10 specifically includes:
向己二酸单乙酯酰氯中加入无水三氯化铝,控制温度在15~20℃,络合反应2h,得到6-氧代-6-氯己酸乙酯络合反应液,然后通入乙烯进行加成反应,加成反应结束,转入去离子水进行水解,分层得到有机相,向有机相加入乙醇和硼氢化钾进行还原反应,然后依次进行氯代反应、环合反应、水解和酸化制备得到α-硫辛酸。Anhydrous aluminum chloride is added to ethyl adipic acid monochloride, the temperature is controlled at 15-20°C, and the complex reaction is carried out for 2 hours to obtain 6-oxo-6-chlorohexanoic acid ethyl ester complex reaction liquid, and then ethylene is introduced for addition reaction. After the addition reaction is completed, deionized water is added for hydrolysis, and the organic phase is obtained by layering. Ethanol and potassium borohydride are added to the organic phase for reduction reaction, and then chlorination reaction, cyclization reaction, hydrolysis and acidification are carried out in sequence to prepare α-lipoic acid.
实施例3Example 3
步骤1,控制温度在20~25℃,依次向溶解釜中加入己二酸单乙酯粗品和去离子水,己二酸单乙酯粗品与去离子水的质量比为1:3,使用10%碳酸氢钠将pH调至6.95;Step 1, controlling the temperature at 20-25° C., adding crude monoethyl adipate and deionized water to a dissolving kettle in sequence, wherein the mass ratio of crude monoethyl adipate to deionized water is 1:3, and adjusting the pH to 6.95 using 10% sodium bicarbonate;
步骤2,控制温度在20~25℃,向溶解釜中加入氯仿进行萃取,氯仿与己二酸单乙酯粗品的质量比为1:1,搅拌25~30min,静置分层,将水相转移到酸化釜,待调酸;Step 2, controlling the temperature at 20-25°C, adding chloroform to the dissolving kettle for extraction, the mass ratio of chloroform to the crude monoethyl adipate being 1:1, stirring for 25-30 minutes, standing for stratification, transferring the aqueous phase to the acidifying kettle for acidification;
步骤3,向氯仿相加入去离子水,氯仿与去离子水的质量比为1:1,然后使用10%碳酸氢钠将pH调至6.95,搅拌反萃取10~15min,将上层水相转到酸化釜,待调酸,对有机相进行氯仿回收;Step 3, adding deionized water to the chloroform phase, the mass ratio of chloroform to deionized water is 1:1, and then adjusting the pH to 6.95 with 10% sodium bicarbonate, stirring and back-extracting for 10-15 minutes, transferring the upper aqueous phase to an acidification kettle, waiting for acid adjustment, and recovering chloroform from the organic phase;
步骤4,控制温度在20~25℃,酸化釜中的水相用15%盐酸将pH调至3.5;Step 4, controlling the temperature at 20-25°C, and adjusting the pH of the aqueous phase in the acidification kettle to 3.5 with 15% hydrochloric acid;
步骤5,控制温度在20~25℃,静置分层,下层为己二酸单乙酯,上层水相待萃取;Step 5, controlling the temperature at 20-25°C, standing and separating the layers, the lower layer is monoethyl adipate, and the upper layer is water to be extracted;
步骤6,酸化釜上层水相氯仿萃取三次,每次萃取后静置分层,每次萃取使用氯仿的质量与步骤1中己二酸单乙酯粗品的质量比为1:1;Step 6, extracting the upper aqueous phase of the acidified kettle with chloroform three times, standing and stratifying after each extraction, and the mass ratio of the chloroform used in each extraction to the mass ratio of the crude monoethyl adipate in step 1 is 1:1;
步骤7,水相第三次萃取后排废,将氯仿相与步骤5得到的己二酸单乙酯合并后,使用饱和氯化钠溶液搅拌洗涤25~30min,饱和氯化钠溶液的质量与步骤1中己二酸单乙酯粗品的质量比为0.5:1,静置分层,有机相待浓缩;Step 7, after the aqueous phase is extracted for the third time, the aqueous phase is discharged, the chloroform phase is combined with the monoethyl adipate obtained in step 5, and then the chloroform phase is stirred and washed for 25 to 30 minutes with a saturated sodium chloride solution, wherein the mass ratio of the saturated sodium chloride solution to the crude monoethyl adipate in step 1 is 0.5:1, the organic phase is allowed to stand and the layers are separated, and the organic phase is to be concentrated;
步骤8,控制温度在20~40℃,真空浓缩步骤7的有机相回收氯仿,得到己二酸单乙酯纯品;Step 8, controlling the temperature at 20-40° C., vacuum concentrating the organic phase of step 7 to recover chloroform, and obtaining pure monoethyl adipate;
步骤9,基于己二酸单乙酯纯品制备己二酸单乙酯酰氯;Step 9, preparing monoethyl adipate chloride based on pure monoethyl adipate;
步骤9具体包括:Step 9 specifically includes:
步骤9.1,向反应釜中加入氯仿、己二酸单乙酯纯品,降温至0℃;Step 9.1, add chloroform and pure monoethyl adipate into the reaction kettle and cool to 0°C;
步骤9.2,控制温度在0~10℃,流加氯仿和氯化亚砜;Step 9.2, controlling the temperature at 0-10°C, adding chloroform and thionyl chloride;
步骤9.3,氯化亚砜流加完后,控制温度5~10℃,反应2h;Step 9.3, after the addition of thionyl chloride, the temperature was controlled at 5-10°C and the reaction was carried out for 2 hours;
步骤9.4,升温至40±2℃,保温反应2h;Step 9.4, raise the temperature to 40±2°C and keep the reaction for 2h;
步骤9.5,升温至70±2℃,保温反应1h;Step 9.5, raise the temperature to 70±2°C and keep the reaction for 1 hour;
步骤9.6,反应结束,冷却至15~20℃,得到己二酸单乙酯酰氯;Step 9.6, after the reaction is completed, the mixture is cooled to 15-20° C. to obtain ethyl adipic acid chloride;
步骤10,基于己二酸单乙酯酰氯制备α-硫辛酸;Step 10, preparing α-lipoic acid based on ethyl adipic acid chloride;
步骤10具体包括:Step 10 specifically includes:
向己二酸单乙酯酰氯中加入无水三氯化铝,控制温度在15~20℃,络合反应2h,得到6-氧代-6-氯己酸乙酯络合反应液,然后通入乙烯进行加成反应,加成反应结束,转入去离子水进行水解,分层得到有机相,向有机相加入乙醇和硼氢化钾进行还原反应,然后依次进行氯代反应、环合反应、水解和酸化制备得到α-硫辛酸。Anhydrous aluminum chloride is added to ethyl adipic acid monochloride, the temperature is controlled at 15-20°C, and the complex reaction is carried out for 2 hours to obtain 6-oxo-6-chlorohexanoic acid ethyl ester complex reaction liquid, and then ethylene is introduced for addition reaction. After the addition reaction is completed, deionized water is added for hydrolysis, and the organic phase is obtained by layering. Ethanol and potassium borohydride are added to the organic phase for reduction reaction, and then chlorination reaction, cyclization reaction, hydrolysis and acidification are carried out in sequence to prepare α-lipoic acid.
对比例1Comparative Example 1
对比例1与实施例1基本相同,不同之处在于,对比例1中,步骤1和步骤3均使用10%碳酸氢钠将pH调至6.80。Comparative Example 1 is substantially the same as Example 1, except that in Comparative Example 1, both Step 1 and Step 3 use 10% sodium bicarbonate to adjust the pH to 6.80.
对比例2Comparative Example 2
对比例2与实施例1基本相同,不同之处在于,对比例2中,步骤1和步骤3均使用10%碳酸氢钠将pH调至7.0。Comparative Example 2 is substantially the same as Example 1, except that in Comparative Example 2, both Step 1 and Step 3 use 10% sodium bicarbonate to adjust the pH to 7.0.
对比例3Comparative Example 3
对比例3与实施例1基本相同,不同之处在于,对比例3中,步骤4酸化釜中的水相用15%盐酸将pH调至2.3。Comparative Example 3 is substantially the same as Example 1, except that in Comparative Example 3, the pH of the aqueous phase in the acidification kettle in step 4 is adjusted to 2.3 with 15% hydrochloric acid.
对比例4Comparative Example 4
对比例4与实施例1基本相同,不同之处在于,对比例4中,步骤4酸化釜中的水相用15%盐酸将pH调至3.7。Comparative Example 4 is substantially the same as Example 1, except that in Comparative Example 4, the pH of the aqueous phase in the acidification kettle in step 4 is adjusted to 3.7 with 15% hydrochloric acid.
对比例5Comparative Example 5
对比例5与实施例1基本相同,不同之处在于,对比例5中,步骤2,控制温度在20~25℃,向溶解釜中加入氯仿进行萃取,氯仿与己二酸单乙酯粗品的质量比为1:2。Comparative Example 5 is substantially the same as Example 1, except that, in Comparative Example 5, in step 2, the temperature is controlled at 20-25° C., chloroform is added to the dissolving kettle for extraction, and the mass ratio of chloroform to the crude monoethyl adipate is 1:2.
对比例6Comparative Example 6
对比例6与实施例1基本相同,不同之处在于,对比例6中,步骤1使用10%氢氧化钠将pH调至6.9。Comparative Example 6 is substantially the same as Example 1, except that in Comparative Example 6, step 1 uses 10% sodium hydroxide to adjust the pH to 6.9.
对比例7Comparative Example 7
对比例7与实施例1基本相同,不同之处在于,对比例7中,步骤3使用10%氢氧化钠将pH调至6.9。Comparative Example 7 is substantially the same as Example 1, except that in Comparative Example 7, step 3 uses 10% sodium hydroxide to adjust the pH to 6.9.
对比例8Comparative Example 8
先按照授权公告号为CN107043327B的中国发明专利中公开的工艺技术路线制备得到己二酸单乙酯,然后采用实施例1中的步骤9和步骤10制备得到α-硫辛酸。First, monoethyl adipate was prepared according to the process technology route disclosed in the Chinese invention patent with authorization announcement number CN107043327B, and then α-lipoic acid was prepared by using steps 9 and 10 in Example 1.
实验测试Experimental test
采用液相色谱检测各实施例和对比例中,得到的己二酸单乙酯的纯度、己二酸二乙酯的含量,采用气相色谱检测各实施例和对比例中,6-氧代-6-氯己酸乙酯的纯度、杂质A的含量,并计算己二酸单乙酯的收率以及α-硫辛酸的收率。The purity of monoethyl adipate and the content of diethyl adipate obtained in each embodiment and comparative example were detected by liquid chromatography, the purity of ethyl 6-oxo-6-chlorohexanoate and the content of impurity A in each embodiment and comparative example were detected by gas chromatography, and the yield of monoethyl adipate and the yield of α-lipoic acid were calculated.
液相色谱的色谱柱采用Superlu C18-AQ 5um,250mm×4.6mm,柱温30℃,波长210nm,进样量20μL,运行时间40min,流速1.0mL/min,流动相如表1。The chromatographic column used for liquid chromatography was Superlu C18-AQ 5um, 250mm×4.6mm, column temperature 30°C, wavelength 210nm, injection volume 20μL, running time 40min, flow rate 1.0mL/min, and the mobile phase was as shown in Table 1.
采用面积归一化法计算己二酸二乙酯(RRT1.3)的含量。The content of diethyl adipate (RRT1.3) was calculated by area normalization method.
表1Table 1
气相色谱的色谱柱采用SE-54(30m×0.32mm,1µm),气化温度300℃,检测器温度300℃,进样量20μL,分流比1:5,运行时间29.75min,氮气流量30mL/min,氢气流量40mL/min,空气流量400mL/min,柱流量3.23mL/min。柱温:初始温度130℃维持3min,以8℃/min升至200℃维持7min,然后以10℃/min升温至250℃维持6min。The gas chromatography column used was SE-54 (30m×0.32mm, 1µm), the vaporization temperature was 300°C, the detector temperature was 300°C, the injection volume was 20μL, the split ratio was 1:5, the running time was 29.75min, the nitrogen flow rate was 30mL/min, the hydrogen flow rate was 40mL/min, the air flow rate was 400mL/min, and the column flow rate was 3.23mL/min. Column temperature: initial temperature was 130°C and maintained for 3min, then increased to 200°C at 8°C/min and maintained for 7min, then increased to 250°C at 10°C/min and maintained for 6min.
采用面积归一化法计算杂质A(RRT3.8)的含量。The content of impurity A (RRT3.8) was calculated using the area normalization method.
图3至图24展示了各实施例和各对比例的液相色谱、气相色谱的结果,相关数据统计在表2中。Figures 3 to 24 show the results of liquid chromatography and gas chromatography of each embodiment and each comparative example, and the relevant data are statistically shown in Table 2.
表2Table 2
从表2可以看出,实施例1~3中己二酸单乙酯的纯度、己二酸单乙酯的收率、α-硫辛酸的收率都明显高于各对比例,特别是高于对比例8中己二酸单乙酯的纯度、己二酸单乙酯的收率、α-硫辛酸的收率。实施例1~3中己二酸二乙酯的含量、杂质A的含量明显低于对比例8中己二酸二乙酯的含量、杂质A的含量。As can be seen from Table 2, the purity of monoethyl adipate, the yield of monoethyl adipate, and the yield of α-lipoic acid in Examples 1 to 3 are significantly higher than those in the comparative examples, especially higher than the purity of monoethyl adipate, the yield of monoethyl adipate, and the yield of α-lipoic acid in Comparative Example 8. The content of diethyl adipate and the content of impurity A in Examples 1 to 3 are significantly lower than the content of diethyl adipate and the content of impurity A in Comparative Example 8.
其中,实施例1与对比例1和对比例2相比,由于步骤1和步骤3中pH不在6.85~6.95范围内。当pH偏低时,己二酸二乙酯在水中的溶解度增加;当pH偏高时,己二酸单乙酯水解生成己二酸,最终导致己二酸单乙酯的纯度和收率、α-硫辛酸的收率降低。Among them, compared with Comparative Examples 1 and 2, in Example 1, the pH in Step 1 and Step 3 is not within the range of 6.85 to 6.95. When the pH is low, the solubility of diethyl adipate in water increases; when the pH is high, monoethyl adipate is hydrolyzed to generate adipic acid, which ultimately leads to a decrease in the purity and yield of monoethyl adipate and the yield of α-lipoic acid.
实施例1与对比例3和对比例4相比,由于步骤4中pH不在2.5~3.5范围内。当pH偏低(酸性更强),己二酸单乙酯在酸性条件水解生成己二酸;当pH偏高(酸性更弱),己二酸二乙酯在氯仿中溶解度增加,导致己二酸单乙酯的纯度和收率、α-硫辛酸的收率降低。Compared with Comparative Examples 3 and 4, in Example 1, the pH in step 4 is not within the range of 2.5 to 3.5. When the pH is low (stronger acidity), monoethyl adipate is hydrolyzed to generate adipic acid under acidic conditions; when the pH is high (weaker acidity), the solubility of diethyl adipate in chloroform increases, resulting in a decrease in the purity and yield of monoethyl adipate and the yield of α-lipoic acid.
实施例1与对比例5相比,由于步骤2中氯仿与己二酸单乙酯粗品的质量比不是1:1,减少了氯仿的用量,己二酸二乙酯并未被充分萃取,导致己二酸单乙酯的纯度和收率、α-硫辛酸的收率降低。Compared with Comparative Example 5, in Example 1, since the mass ratio of chloroform to crude monoethyl adipate in step 2 is not 1:1, the amount of chloroform used is reduced, and diethyl adipate is not fully extracted, resulting in reduced purity and yield of monoethyl adipate and yield of α-lipoic acid.
实施例1与对比例6和对比例7相比,对比例6中步骤1使用了10%氢氧化钠,对比例7中步骤3使用了10%氢氧化钠,由于氢氧化钠碱性较强,容易导致局部偏碱,己二酸单乙酯在碱性条件下水解,酸化后产生己二酸,导致己二酸单乙酯的纯度和收率、α-硫辛酸的收率降低。Compared with Comparative Examples 6 and 7, in Example 1, 10% sodium hydroxide was used in step 1 of Comparative Example 6, and 10% sodium hydroxide was used in step 3 of Comparative Example 7. Since sodium hydroxide has a strong alkalinity, it is easy to cause local alkalinity. Monoethyl adipate is hydrolyzed under alkaline conditions and adipic acid is produced after acidification, resulting in a decrease in the purity and yield of monoethyl adipate and the yield of α-lipoic acid.
综上,本发明提供的α-硫辛酸的制备方法,根据溶解pH 6.85~6.95时,己二酸单乙酯(酸度系数4.69±0.1)反应生成钠盐,溶于水;而己二酸二乙酯和甲苯溶于氯仿,能够针对性的去除己二酸二乙酯和甲苯;酸化萃取时,钠盐与盐酸反应生成己二酸单乙酯,同时根据不同pH,己二酸单乙酯在水中溶解度的差异,获得较高的萃取收率,且该方法避免了高温精馏导致的产品热降解,能够获得高纯度的己二酸单乙酯,该方法操作简单,有效降低了生产成本,不但解决了己二酸二乙酯去除的问题,而且解决了己二酸单乙酯的残留溶剂甲苯参与反应生成杂质的问题,最终能够提高α-硫辛酸的收率。In summary, the preparation method of alpha-lipoic acid provided by the present invention is that when the dissolution pH is 6.85-6.95, monoethyl adipate (acidity coefficient 4.69±0.1) reacts to generate sodium salt, which is soluble in water; diethyl adipate and toluene are dissolved in chloroform, and diethyl adipate and toluene can be removed in a targeted manner; during acid extraction, the sodium salt reacts with hydrochloric acid to generate monoethyl adipate, and at the same time, according to the difference in solubility of monoethyl adipate in water at different pH values, a higher extraction yield is obtained, and the method avoids thermal degradation of the product caused by high-temperature distillation, and can obtain high-purity monoethyl adipate. The method is simple to operate, effectively reduces the production cost, not only solves the problem of removing diethyl adipate, but also solves the problem of residual solvent toluene of monoethyl adipate participating in the reaction to generate impurities, and finally can improve the yield of alpha-lipoic acid.
尽管已经示出和描述了本发明的实施例,本领域的普通技术人员可以理解:在不脱离本发明的原理和宗旨的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。Although the embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the claims and their equivalents.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410552879.4A CN118126019B (en) | 2024-05-07 | 2024-05-07 | A kind of preparation method of alpha-lipoic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410552879.4A CN118126019B (en) | 2024-05-07 | 2024-05-07 | A kind of preparation method of alpha-lipoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CN118126019A true CN118126019A (en) | 2024-06-04 |
CN118126019B CN118126019B (en) | 2024-07-30 |
Family
ID=91237979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410552879.4A Active CN118126019B (en) | 2024-05-07 | 2024-05-07 | A kind of preparation method of alpha-lipoic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118126019B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115894229A (en) * | 2022-11-15 | 2023-04-04 | 福州大学 | A kind of selective synthesis process of monoethyl adipate |
CN116041318A (en) * | 2022-12-29 | 2023-05-02 | 江苏恒沛药物科技有限公司 | A kind of method for preparing lipoic acid |
CN116496159A (en) * | 2023-05-09 | 2023-07-28 | 山东龙辰药业有限公司 | Preparation method of ethyl 6,8-dichloro octoate |
-
2024
- 2024-05-07 CN CN202410552879.4A patent/CN118126019B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115894229A (en) * | 2022-11-15 | 2023-04-04 | 福州大学 | A kind of selective synthesis process of monoethyl adipate |
CN116041318A (en) * | 2022-12-29 | 2023-05-02 | 江苏恒沛药物科技有限公司 | A kind of method for preparing lipoic acid |
CN116496159A (en) * | 2023-05-09 | 2023-07-28 | 山东龙辰药业有限公司 | Preparation method of ethyl 6,8-dichloro octoate |
Also Published As
Publication number | Publication date |
---|---|
CN118126019B (en) | 2024-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112028755A (en) | Method for preparing 1,3 cyclohexanedione | |
CN114573560A (en) | Preparation method of Voranolan fumarate | |
CN104478719B (en) | A kind of preparation method of methyl 4-methoxy acetoacetate | |
CN118126019B (en) | A kind of preparation method of alpha-lipoic acid | |
CN110818765A (en) | Method for isomerizing cis-glycyrrhizic acid | |
CN103360455A (en) | Industrial production method of 5 alpha-androst-2-ene-17-one | |
CN112409196A (en) | Preparation process of aminomethylbenzoic acid based on Delbin reaction | |
CN107056793A (en) | A kind of method that high-yield and high-efficiency synthesizes TNPP, TAPP | |
CN110066240A (en) | A kind of synthetic method of nitrendipine | |
CN101570492B (en) | Chemical method for synthesizing ephedrine | |
CN101003476B (en) | A kind of preparation technology of divalproex sodium | |
CN107698596A (en) | A kind of synthetic method of Allopurinol | |
CN105037167A (en) | Synthetic method of N, N-diaryl-2-bromine-6-naphthylamine and application thereof | |
CN113416142A (en) | Preparation method of 5-ALA intermediate 5-bromolevulinate | |
CN115043816B (en) | Chiral resolution method of selenium octanoic acid | |
CN112794809B (en) | Preparation method of high-purity nepafenac intermediate | |
CN112110803A (en) | Preparation method of 3',5' -dichloro-2, 2, 2-trifluoro acetophenone | |
CN114105900B (en) | Preparation method of 3, 4-diphenyl ketone-1, 2, 5-oxadiazole | |
CN107129466B (en) | Synthetic method of 4-chloro-3-methoxy-2-methylpyridine-N-oxide | |
CN119490406A (en) | Preparation method of 4-formylnaphthalene-1-carboxylic acid methyl ester | |
CN116375583A (en) | A kind of preparation method of 1,3,5-trialkoxy-2,4,6-trinitrobenzene | |
CN111960955B (en) | Preparation method of terbutaline | |
JP2013227273A (en) | Purification method for 4'-[[2-n-propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)-benzimidazole-1-yl]-methyl]-biphenyl-2-carboxylic acid | |
CN117945997A (en) | A kind of synthetic method of 8-hydroxyquinoline | |
CN112409159B (en) | Method for synthesizing mandelic acid by oxidation-chlorination process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |